Dihydroxybenzoic Acid Derivative Bone Filling Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone-grafting and bone-filling materials, such as synthetic bones and BMPs, have limitations in activating osteoblasts for effective bone formation, leading to variable bone-healing periods and high costs.
Innovation Solution
A bone-grafting or bone-filling composition comprising dihydroxybenzoic acid derivatives, specifically ethyl 2,4-dihydroxybenzoate or ethyl 2,5-dihydroxybenzoate, which significantly increase alkaline phosphatase activity, calcium accumulation, and alveolar bone formation, is developed for use in orthopedic and orthodontic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bone-grafting materials (synthetic bones, BMPs) are used, then bone formation can be achieved, but the activation of osteoblasts is insufficient leading to variable bone-healing periods and high costs
Solution Approach 1:
The patent introduces dihydroxybenzoic acid derivatives as a chemical compound that modifies the biological activity parameters of osteoblasts. This compound specifically enhances osteoblast activation, leading to more consistent and predictable bone formation rates, thereby reducing the variability in bone-healing periods while maintaining effective bone formation
Solution Approach 2:
The dihydroxybenzoic acid derivative acts as an intermediary substance that mediates between the conventional bone-grafting materials and the osteoblasts. It enhances the interaction and signaling between these materials and the bone-forming cells, improving the overall effectiveness and consistency of bone formation without requiring complete replacement of existing materials
2Reliability
If conventional bone-grafting materials are used, then bone formation can be achieved, but the cost is high
Solution Approach 1:
The patent employs dihydroxybenzoic acid derivatives, which are relatively inexpensive chemical compounds compared to conventional bone-grafting materials like BMPs. This approach replaces expensive biological materials with more affordable synthetic compounds that achieve similar or superior bone formation effectiveness, significantly reducing treatment costs
Solution Approach 2:
By changing the chemical composition to include dihydroxybenzoic acid derivatives, the patent achieves cost reduction while maintaining bone formation effectiveness. The compound enhances osteoblast activation at lower costs compared to conventional materials, providing a more economically viable solution for bone regeneration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dihydroxybenzoic acid derivatives effectively activate osteoblasts for enhanced bone formation, fracture healing, and tooth growth, offering a cost-effective alternative for bone regeneration in various forms like artificial bones, joints, and dental implants.
Implementation Method 1
the dihydroxybenzoic acid derivative, as defined in claim 1, increases an activity of osteoblasts, thereby inducing bone formation
Implementation Method 2
significantly increase alkaline phosphatase activity, calcium accumulation, and alveolar bone formation
Data Source
AI summary
Provided is a bone-transplant or bone-filling composition, which comprises a dihydroxybenzoic acid derivative which has been newly demonstrated to increase the activity of osteoblasts and so induce bone formation.